CRISTALLI, Gloria
 Distribuzione geografica
Continente #
NA - Nord America 15.653
EU - Europa 5.971
AS - Asia 5.108
SA - Sud America 734
AF - Africa 63
Continente sconosciuto - Info sul continente non disponibili 46
OC - Oceania 8
Totale 27.583
Nazione #
US - Stati Uniti d'America 15.067
CN - Cina 2.512
RU - Federazione Russa 1.624
SG - Singapore 1.416
DE - Germania 833
IT - Italia 770
BR - Brasile 646
SE - Svezia 559
CA - Canada 534
UA - Ucraina 522
GB - Regno Unito 508
HK - Hong Kong 417
FR - Francia 332
FI - Finlandia 278
PL - Polonia 226
TR - Turchia 188
KR - Corea 179
IE - Irlanda 112
VN - Vietnam 106
IN - India 64
EU - Europa 45
BE - Belgio 38
CZ - Repubblica Ceca 36
ES - Italia 35
JP - Giappone 34
AR - Argentina 33
MX - Messico 31
ZA - Sudafrica 30
IR - Iran 29
BD - Bangladesh 26
IQ - Iraq 23
NL - Olanda 20
UZ - Uzbekistan 17
RO - Romania 14
EC - Ecuador 13
VE - Venezuela 13
SA - Arabia Saudita 11
CL - Cile 10
MA - Marocco 10
AE - Emirati Arabi Uniti 9
AT - Austria 9
IL - Israele 9
AZ - Azerbaigian 8
JO - Giordania 8
KE - Kenya 8
LT - Lituania 8
CO - Colombia 7
ID - Indonesia 7
PY - Paraguay 7
RS - Serbia 7
CH - Svizzera 6
PK - Pakistan 6
TN - Tunisia 6
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
AM - Armenia 4
CR - Costa Rica 4
LV - Lettonia 4
NP - Nepal 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
AU - Australia 3
BG - Bulgaria 3
BO - Bolivia 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GE - Georgia 3
HR - Croazia 3
KZ - Kazakistan 3
LU - Lussemburgo 3
MY - Malesia 3
PH - Filippine 3
PT - Portogallo 3
AL - Albania 2
DK - Danimarca 2
EE - Estonia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
KH - Cambogia 2
NO - Norvegia 2
PE - Perù 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
BB - Barbados 1
BH - Bahrain 1
BT - Bhutan 1
CM - Camerun 1
GA - Gabon 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KI - Kiribati 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MQ - Martinica 1
MR - Mauritania 1
MT - Malta 1
Totale 27.576
Città #
Woodbridge 1.513
Fairfield 1.481
Jacksonville 1.351
Ashburn 1.114
Chandler 1.043
Houston 1.043
Wilmington 679
Seattle 666
Ann Arbor 641
Singapore 602
Boardman 521
Nanjing 510
Cambridge 498
Hong Kong 414
Toronto 340
Beijing 326
Dallas 245
The Dalles 243
Dearborn 216
San Mateo 207
Düsseldorf 196
Columbus 191
Kraków 189
Los Angeles 185
Seoul 176
Lawrence 169
Princeton 169
Tongling 169
Lachine 155
Istanbul 148
Nanchang 147
Ogden 143
New York 138
Buffalo 124
Moscow 114
Dublin 112
Shenyang 92
London 87
Helsinki 84
Kunming 83
Guangzhou 78
Tianjin 78
Hebei 76
Shanghai 72
Milan 71
San Diego 71
Chicago 64
Jiaxing 58
São Paulo 53
Munich 48
Camerino 47
Council Bluffs 47
Venezia 47
Jinan 45
Brussels 38
Changsha 38
Ningbo 37
Wuhan 35
Santa Clara 33
Stockholm 33
Tokyo 32
Hangzhou 30
Denver 29
Hefei 28
Orange 28
Redwood City 28
Zhengzhou 28
Ho Chi Minh City 27
Warsaw 27
Frankfurt am Main 25
Hanoi 25
Brooklyn 24
Falls Church 24
Philadelphia 24
Verona 24
Boston 23
Brno 23
Detroit 23
Kocaeli 23
Taizhou 22
Lanzhou 21
Norwalk 21
Venice 21
Washington 21
Auburn Hills 20
Johannesburg 20
Orem 20
Phoenix 20
Atlanta 19
Leawood 19
Nürnberg 19
Bremen 18
Poplar 18
Ardabil 17
Chennai 17
Turku 17
Belo Horizonte 16
Jinhua 16
Montreal 16
Rio de Janeiro 16
Totale 18.482
Nome #
Adenine based acyclic-nucleotides as novel P2X3 receptor ligands 270
Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones 265
Neuropeptide S Receptor: recent updates on non-peptide antagonist discovery 250
2-Aralkynyl and 2-Heteroalkynyl derivatives of Adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists 242
Levels of polychlorinated biphenyls in fish and shellfish from the Adriatic Sea 234
A preliminary matrix-assisted laser desorption/ionization time-of-flight approach for the characterization of Italian lentil varieties 232
2-Alkynyl derivatives of adenosine and adenosine-5'-N-ethyluronamide as selective agonists at A2 adenosine receptors 230
Functional properties of subunit interactions in human cytidine deaminase 228
Adenine and deazaadenine nucleoside and deoxynucleoside analogues: inhibition of viral replication of sheep MVV (in vitro model for HIV) and bovine BHV-1 227
Composition and biological activity of essential oil of Achillea ligustica All. (Asteraceae) naturalized in central Italy: ideal candidate for anti-cariogenic formulations 223
2-Substituted N-ethylcarboxamidoadenosine derivatives as high affinity agonists at human A(3) adenosine receptors 223
3'-Deoxyribofuranose derivatives of 1-deaza and 3-deaza adenosine and their activity as adenosine deaminase inhibitors 222
9-ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities 222
Synthesis and evaluation of hexitol nucleoside congeners as ambiguous nucleosides 220
Human cytidine deaminase: understanding the catalytic mechanism 220
A(2A) adenosine receptor agonists reduce both high-palatability and low-palatability food intake in female rats 219
Complex of dipeptidyl peptidase II with adenosine deaminase. 216
Determination of ink photoinitiators in packaged beverages by gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry 216
Simultaneous Determination of Squalene, α-Tocopherol and β-Carotene in Table Olives by Solid Phase Extraction and High-Performance Liquid Chromatography with Diode Array Detection 215
Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs 214
Purine and deazapurine nucleosides: synthetic approaches, molecular modeling and biological activity 211
Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17 211
Inhibition studies on membrane Adenosine Deaminase from human placenta 211
Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y(1) receptor antagonists and partial agonists 207
Adenosine deaminase: Functional implications and different classes of inhibitors 207
2-Alkynyl derivatives of Adenosine-5'-N-ethyluronamide (NECA): selective A2 adenosine receptor agonists with potent inhibitory activity on Platelet aggregation 206
8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A(2A) and A(2B) receptors ligands 206
Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles 205
“Third Joint Italian-German Purine Club Meeting - Purinergic Receptors: New Frontiers for Novel Therapies” 205
Optimization of espresso machine parameters through the analysis of coffee odorants by HS-SPME–GC/MS 200
Molecular modeling study on potent and selective adenosine A3 receptor agonists. 200
Evidence for the existence of a specific G protein-coupled receptor activated by guanosine 200
Antiviral properties of deazaadenine nucleoside derivatives 199
A(2A) Adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists 198
CX3CL1-induced modulation at CA1 synapses reveals multiple mechanisms of EPSC modulation involving adenosine receptor subtypes. 198
2- And 8- alkynyladenosines: conformational studies and docking to human adenosine A(3) receptor can explain their different biological behavior 195
Adenosine A(2A) receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease 195
Molecular modeling studies on the human neuropeptide S receptor and its antagonists. 195
Comparative study of aroma profile and phenolic content of Montepulciano monovarietal red wines from the Marches and Abruzzo Regions of Italy using HS-SPME-GC-MS and HPLC-MS 194
Glandular trichomes and essential oil composition of endemic Sideritis italica (Mill.) Greuter et Burdet from central Italy 193
Strong enhancement of vibrational relaxation by Watson-Crick base pairing 192
Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch 192
Diazepinone nucleosides as inhibitors of cytidine deaminase 190
Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family 190
Purification of human cytidine deaminase : Molecular and enzymatic characterization and inhibition by synthetic pyrimidine analogs 189
Functional residues at the active site of bovine brain adenosine deaminase. 189
Identification of alpha(1)-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens 188
2-Alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors 188
Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1 188
Adenosine receptor modeling: what does the A2A crystal structure tell us? 187
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. 186
"N-Cycloalkylalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists at the A1 adenosine receptor 184
Further studies on intersubunit interactions in human cytidine deaminase 183
The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors 183
New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile 180
Synthesis and receptor affinity of polysubstituted adenosines 180
Chemical and pharmacological profile of selective adenosine receptor agonists 180
2-substituted 5 '-N-methylcarboxamidoadenosine (MECA) derivatives as A(3) adenosine receptor ligands 179
Ring opening reactions: synthesis of AICAR analogs as potential antimetabolite agents 178
2-phenylhydroxypropynyladenosine derivatives as high potent agonists at A(2B) adenosine receptor subtype 178
Synthesis and evaluation of anti-HIV-1 and antitumor activity of 2',3'-didehydro-2',3'-dideoxy-3-deazaadenosine, 2',3'-dideoxy-3-deazaadenosine and some 2',3'-dideoxy-3-deazaadenosine 5'-dialkyl phosphates 177
2- And 8-alkynyl-9-ethyladenines: Synthesis and biological activity at human and rat adenosines receptors 177
GPCRs as therapeutic targets: a view on adenosine receptors structure and functions, and molecular modeling support 175
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists 175
Introduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A(3) adenosine receptor 174
Essential oil from fruits and roots of Ferulago campestris (Apiaceae): composition and antioxidant and anti-Candida activity 174
Kinetic and structural analysis of the inhibition of adenosine deaminase by acetaminophen 173
Purine and 1-deazapurine ribonucleosides and deoxyribonucleosides: synthesis and biological activity 173
Synthesis and adenosine deaminase inhibitory activity of 3’-deoxy-1-deazaadenosines 172
Potent and selective ligands for adenosine binding sites 172
Unexpected synthesis of acyclic adenine nucleosides 171
[3H]HEMADO – a novel tritiated agonist selective for the human adenosine A(3) receptor 169
Alkannin/shikonin mixture from roots of Onosma echioides (L.) L.: Extraction method study and quantification 168
Innovative functional cAMP assay: application to the pharmacological characterization of GPR17 168
A(2B) adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyladenosine and NECA derivatives 167
A2A adenosine receptor antagonists 167
Chemical differences in volatiles between Melittis melissophyllum L subsp melissophyllum and subsp albida (Guss) PW Ball (Lamiaceae) determined by solid phase microextraction (SPME) coupled to GC/FID and GC/MS 167
Pharmacological postconditioning of the rabbit heart with non-selective, A1, A2A and A3 adenosine receptor agonists 167
Coupling of 2,6-disubstituted purines to ribose-modified sugars 166
Synthesis, structure-affinity relationships and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists 166
Cytidine dEaminase from human placenta 166
A2A adenosine receptor antagonists 165
N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists of the A1 adenosine receptor 165
Adenosine deaminase inhibitors: synthesis, diastereoisomeric resolution and biological activity of 1-(2-hydroxy-3-nonyl)-1,2,4-triazole-3-carboxamide 164
Photoinactivation studies on adenosine deaminase 164
Volatile components in whole and different plant parts of Bastard Balm (Melittis melissophyllum L, Lamiaceae) collected in central Italy and Slovakia 164
2-ChloroATP exerts anti-tumoral actions not mediated by P2 receptors in neuronal and glial cells line 163
Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists. Synthesis, structure-affinity relationships and molecular modeling studies 163
Synthesis and adenosine receptor affinity and potency of 8-alkynyl derivatives of adenosine 163
Well water in central Italy: Analysis of herbicide residues as potential pollutants of untreated crops 162
Structure-activity relationships of adenosine deaminase inhibitors 162
Synthesis and stability studies of 2 ',3 ',5 '-tri-O-acetyl-2-amino(-N-6-cyclopentyl)-1-deazaadenosines 161
Coupling of 2,6-dichloropurine and 2,6-dichlorodeazapurines with ribose and ribose modified sugars 161
Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists 161
Effects of 5 '-phosphate derivatives of 2-hexynyl adenosine and 2-phenylethynyl adenosine on responses of human platelets mediated by P2Y receptors 161
Human cytidine deaminase: a three dimensional homology model of a tetrameric metallo-enzyme inferred from the crystal structure of distantly related dimeric homologue 160
Human adenosine A3 receptor as selective target of new 2-aralkynyl-N6-methyl-MECA derivatives 160
Evidence for the functional expression and pharmacological characterization of adenine receptors in native cells and tissues 159
Synthesis and antitumor activity of 2-ß-D-ribofuranosyloxazole-4-carboxamide (oxazofurin). 159
Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas 158
Totale 18.987
Categoria #
all - tutte 109.462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.462


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.903 0 0 0 0 0 215 403 31 254 75 582 343
2021/20221.875 188 457 33 95 126 116 67 140 127 206 106 214
2022/20232.475 225 87 72 422 314 375 3 160 489 122 154 52
2023/20241.542 260 92 90 51 73 168 43 46 169 36 16 498
2024/20254.981 150 147 448 239 149 300 541 1.260 379 353 243 772
2025/20263.347 441 390 648 935 799 134 0 0 0 0 0 0
Totale 27.804